Literature DB >> 19931508

Definitive evidence that a single N-glycan among three glycans on inducible costimulator is required for proper protein trafficking and ligand binding.

Naoki Kamei1, Rie Fukui, Yoshiyuki Suzuki, Yasuhiro Kajihara, Mitsuhiro Kinoshita, Kazuaki Kakehi, Hironobu Hojo, Katsunari Tezuka, Takashi Tsuji.   

Abstract

Glycosylation is a widespread post-translational modification found in glycoproteins. Glycans play key roles in protein folding, quality control in the endoplasmic reticulum (ER) and protein trafficking within cells. However, it remains unclear whether all positions of protein glycosylation are involved in glycan functions, or if specific positions have individual roles. Here we demonstrate the integral involvement of a specific N-glycan from amongst the three glycans present on inducible costimulator (ICOS), a T-cell costimulatory molecule, in proper protein folding and intracellular trafficking to the cell surface membrane. We found that glycosylation-defective mutant proteins lacking N-glycan at amino-acid position 89 (N89), but not proteins lacking either N23 or N110, were retained within the cell and were not detected on the cell surface membrane. Additional evidence suggested that N89 glycosylation was indirectly involved in ICOS ligand binding. These data suggest that amongst the three putative ICOS glycosylation sites, N89 is required for proper ICOS protein folding in the ER, intracellular trafficking and ligand binding activity. This study represents a substantial contribution to the current mechanistic understanding of the necessity and potential functions of a specific N-glycan among the multiple glycans of glycoproteins. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19931508     DOI: 10.1016/j.bbrc.2009.11.098

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  GABRB3 mutation, G32R, associated with childhood absence epilepsy alters α1β3γ2L γ-aminobutyric acid type A (GABAA) receptor expression and channel gating.

Authors:  Katharine N Gurba; Ciria C Hernandez; Ningning Hu; Robert L Macdonald
Journal:  J Biol Chem       Date:  2012-02-02       Impact factor: 5.157

Review 2.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2014-05-26       Impact factor: 10.946

3.  Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1.

Authors:  Chia-Wei Li; Seung-Oe Lim; Ezra M Chung; Yong-Soo Kim; Andrew H Park; Jun Yao; Jong-Ho Cha; Weiya Xia; Li-Chuan Chan; Taewan Kim; Shih-Shin Chang; Heng-Huan Lee; Chao-Kai Chou; Yen-Liang Liu; Hsin-Chih Yeh; Evan P Perillo; Andrew K Dunn; Chu-Wei Kuo; Kay-Hooi Khoo; Jennifer L Hsu; Yun Wu; Jung-Mao Hsu; Hirohito Yamaguchi; Tzu-Hsuan Huang; Aysegul A Sahin; Gabriel N Hortobagyi; Stephen S Yoo; Mien-Chie Hung
Journal:  Cancer Cell       Date:  2018-02-12       Impact factor: 31.743

4.  Aberrant Protein Glycosylation in Brain Cancers, with Emphasis on Glioblastoma.

Authors:  Livia Rosa-Fernandes; Sueli Mieko Oba-Shinjo; Janaina Macedo-da-Silva; Suely Kazue Nagahashi Marie; Giuseppe Palmisano
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

5.  FUT8-mediated aberrant N-glycosylation of B7H3 suppresses the immune response in triple-negative breast cancer.

Authors:  Yun Huang; Hai-Liang Zhang; Zhi-Ling Li; Tian Du; Yu-Hong Chen; Yan Wang; Huan-He Ni; Kai-Ming Zhang; Jia Mai; Bing-Xin Hu; Jun-Hao Huang; Li-Huan Zhou; Dong Yang; Xiao-Dan Peng; Gong-Kan Feng; Jun Tang; Xiao-Feng Zhu; Rong Deng
Journal:  Nat Commun       Date:  2021-05-11       Impact factor: 14.919

Review 6.  Glycosylation of Immune Receptors in Cancer.

Authors:  Ruoxuan Sun; Alyssa Min Jung Kim; Seung-Oe Lim
Journal:  Cells       Date:  2021-05-04       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.